[Efficacy and safety of TAM-sparing antiretroviral regimens in naïve HIV-positive patients].
To assess the potency, efficacy and toxicity of abacavir/lamivudine (ABC/3TC) versus tenfovir/emcitrabine (TDF/FTC) with efavirenz (EFV) in naive patients with HIV infection a prospective observational study was carried out to evaluate immunovirological parameters every three months and metabolic parameters every six months. In all, 21 patients were enrolled (10 on ABC/3TC and 11 on TDF/FTC). Fisher's test revealed no statistically significant difference between the two arms in terms of immunological recovery and control of viral replication. For metabolic parameters at week 48 no statistically significant differences were noted between the two arms. The two ABC/3TC and TDF/FTC backbones showed the same potency; ABC had a more negative impact on metabolic parameters without statistical power.
Unità Operativa di Malattie Infettive, Ospedale Policlinico G.B. Rossi, Borgo Roma, Verona, Italy.
Martina
M
Gottardi
Massimiliano
M
Lanzafame
Emanuela
E
Lattuada
Fabio
F
Soldani
Fabio
F
Boccafoglio
Ercole
E
Concia
D000225:Adenine / Q000031:analogs & derivatives; D000328:Adult; D000480:Alkynes; D019380:Anti-HIV Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D048588:Benzoxazines / Q000494:pharmacology / Q000627:therapeutic use; D018791:CD4 Lymphocyte Count; D003521:Cyclopropanes; D003841:Deoxycytidine / Q000031:analogs & derivatives; D015224:Dideoxynucleosides; D004359:Drug Therapy, Combination; D000068679:Emtricitabine; D005260:Female; D015658:HIV Infections / Q000097:blood / Q000188:drug therapy*; D015497:HIV-1; D006801:Humans; D006946:Hyperinsulinism / Q000139:chemically induced; D006949:Hyperlipidemias / Q000139:chemically induced; D019259:Lamivudine; D008297:Male; D008875:Middle Aged; D009154:Mutation; D063065:Organophosphonates; D011446:Prospective Studies; D000068698:Tenofovir; D013936:Thymidine / Q000378:metabolism; D016896:Treatment Outcome; D055815:Young Adult; D000099227:Abacavir
D000225:Adenine; D000480:Alkynes; D019380:Anti-HIV Agents; D048588:Benzoxazines; D003521:Cyclopropanes; D003841:Deoxycytidine; D015224:Dideoxynucleosides; D000068679:Emtricitabine; D019259:Lamivudine; D063065:Organophosphonates; D000068698:Tenofovir; D013936:Thymidine; D000099227:Abacavir; C098320:efavirenz